NO20005947L - Fremgangsmåte for å öke benhardhet og stivhet og redusere frakturer - Google Patents

Fremgangsmåte for å öke benhardhet og stivhet og redusere frakturer

Info

Publication number
NO20005947L
NO20005947L NO20005947A NO20005947A NO20005947L NO 20005947 L NO20005947 L NO 20005947L NO 20005947 A NO20005947 A NO 20005947A NO 20005947 A NO20005947 A NO 20005947A NO 20005947 L NO20005947 L NO 20005947L
Authority
NO
Norway
Prior art keywords
stiffness
steps
increase bone
bone hardness
reduce fractures
Prior art date
Application number
NO20005947A
Other languages
English (en)
Other versions
NO20005947D0 (no
NO323984B1 (no
Inventor
Janet Mary Hock
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26792729&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20005947(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20005947D0 publication Critical patent/NO20005947D0/no
Publication of NO20005947L publication Critical patent/NO20005947L/no
Publication of NO323984B1 publication Critical patent/NO323984B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
NO20005947A 1998-08-19 2000-11-24 Anvendelse av paratyroidhormon for fremstilling av et preparat for a redusere benfraktur NO323984B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9715198P 1998-08-19 1998-08-19
US9974698P 1998-09-10 1998-09-10
PCT/US1999/018961 WO2000010596A1 (en) 1998-08-19 1999-08-19 Method of increasing bone toughness and stiffness and reducing fractures

Publications (3)

Publication Number Publication Date
NO20005947D0 NO20005947D0 (no) 2000-11-24
NO20005947L true NO20005947L (no) 2000-11-24
NO323984B1 NO323984B1 (no) 2007-07-30

Family

ID=26792729

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20005947A NO323984B1 (no) 1998-08-19 2000-11-24 Anvendelse av paratyroidhormon for fremstilling av et preparat for a redusere benfraktur
NO20072983A NO20072983L (no) 1998-08-19 2007-06-11 Anvendelse av paratyroidhormon for fremstilling av et medikament for a redusere risiko for frakturer

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20072983A NO20072983L (no) 1998-08-19 2007-06-11 Anvendelse av paratyroidhormon for fremstilling av et medikament for a redusere risiko for frakturer

Country Status (33)

Country Link
US (2) US6977077B1 (no)
EP (3) EP1059933B1 (no)
JP (5) JP2002523375A (no)
KR (1) KR100454207B1 (no)
CN (1) CN1205997C (no)
AR (1) AR033639A1 (no)
AT (1) ATE231000T1 (no)
AU (1) AU746277B2 (no)
BR (1) BR9909445A (no)
CA (1) CA2325371C (no)
CO (1) CO5130020A1 (no)
CY (2) CY1113343T1 (no)
CZ (1) CZ301017B6 (no)
DE (2) DE69904918T2 (no)
DK (4) DK2266598T3 (no)
DZ (1) DZ2873A1 (no)
EA (1) EA003362B1 (no)
ES (4) ES2549551T3 (no)
HK (3) HK1030545A1 (no)
HR (1) HRP20000755A2 (no)
HU (2) HU230697B1 (no)
ID (1) ID29039A (no)
IL (2) IL138829A0 (no)
MY (1) MY129227A (no)
NO (2) NO323984B1 (no)
NZ (1) NZ507056A (no)
PE (1) PE20001089A1 (no)
PL (1) PL201688B1 (no)
PT (4) PT1769804E (no)
TR (1) TR200003455T2 (no)
TW (1) TW576747B (no)
UA (1) UA72205C2 (no)
WO (1) WO2000010596A1 (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770623B1 (en) * 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
US20040033950A1 (en) * 2000-09-26 2004-02-19 Hock Janet M. Method of increasing bone toughness and stiffness and reducing fractures
DZ2873A1 (fr) * 1998-08-19 2003-12-15 Lilly Co Eli Procédé pour augmenter la dureté et la rigidité osseuse.
AU7362900A (en) * 1999-09-20 2001-04-24 Eli Lilly And Company Method for monitoring treatment with a parathyroid hormone
US7247609B2 (en) 2001-12-18 2007-07-24 Universitat Zurich Growth factor modified protein matrices for tissue engineering
WO2003059291A2 (en) 2002-01-10 2003-07-24 Osteotrophin Llc Treatment of bone disorders with skeletal anabolic drugs
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
JP2007505883A (ja) * 2003-09-19 2007-03-15 ファイザー・プロダクツ・インク ２−アルキリデン−１９−ノル−ビタミンｄ誘導体及び副甲状腺ホルモンの組合せを含んでなる医薬組成物及び方法
RU2006143544A (ru) * 2004-05-10 2008-06-20 Нэстек Фармасьютикал Кампани Инк. (Us) Композиции и способ для облегченной чресслизистой доставки паратиреоидного гормона
US20060127320A1 (en) * 2004-05-10 2006-06-15 Nastech Pharmaceutical Company Inc. Method of delivering parathyroid hormone to a human
US20060189533A1 (en) * 2004-05-10 2006-08-24 Nastech Pharmaceutical Company Inc. Stable pharmaceutical dosage forms of teriparatide
US20060052305A1 (en) * 2004-05-10 2006-03-09 Nastech Pharmaceutical Company Inc. Method of treating osteoporosis using intranasal parathyroid hormone
MXPA06013168A (es) 2004-05-13 2007-05-15 Johnson & Johnson Aparato y metodo para el suministro transdermico de agentes de la hormona paratiroidea.
US7648965B2 (en) 2004-05-14 2010-01-19 Unigene Laboratories Inc. Method for fostering bone formation and preservation
US20060069021A1 (en) * 2004-08-13 2006-03-30 Nastech Pharmaceutical Company Inc. Compositions and methods for intranasal administration of inactive analogs of PTH or inactivated preparations of PTH or PTH analogs
US8575101B2 (en) 2005-01-06 2013-11-05 Kuros Biosurgery Ag Supplemented matrices for the repair of bone fractures
WO2006073711A2 (en) * 2005-01-06 2006-07-13 Kuros Biosurgery Ag Use of a matrix comprising a contrast agent in soft tissues
CN101217972B (zh) * 2005-05-11 2013-05-29 尤尼基因实验室公司 促进骨形成和保持的方法
US20070173447A1 (en) * 2005-10-25 2007-07-26 Nastech Pharmaceutical Company Inc. Method for treating osteoporosis by intranasal delivery of teriparatide with an anti-resorptive agent
US7994129B2 (en) * 2005-11-10 2011-08-09 Michigan Technological University Methods of using black bear parathyroid hormone
US20080051332A1 (en) * 2005-11-18 2008-02-28 Nastech Pharmaceutical Company Inc. Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone
US20080119408A1 (en) * 2006-07-07 2008-05-22 Nastech Pharmaceutical Company Inc. Pth formulations for intranasal delivery
EP1961765A1 (en) * 2006-12-08 2008-08-27 Zealand Pharma A/S Truncated PTH peptides with a cyclic conformation
EP2136850B1 (en) 2007-04-13 2012-02-01 Kuros Biosurgery AG Polymeric tissue sealant
US20110137243A1 (en) * 2007-09-06 2011-06-09 Abbott Cardiovascular Systems Inc. Coating On A Balloon Device
EP2217260B1 (en) * 2007-12-04 2016-11-09 Ben-Gurion University Of The Negev Research And Development Authority Amphiphilic peptide matrices for treatment of osteoporosis
JP2012512812A (ja) 2007-12-28 2012-06-07 クロス・バイオサージェリー・アクチェンゲゼルシャフト フィブリンフォームに組込まれたｐｄｇｆ融合タンパク質
AU2010293488B2 (en) 2009-09-09 2014-11-27 Asahi Kasei Pharma Corporation PTH-containing therapeutic/prophylactic agent for osteoporosis, characterized in that PTH is administered once a week in a unit dose of 100 to 200 units
WO2011071480A1 (en) 2009-12-07 2011-06-16 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US9295663B2 (en) 2010-07-14 2016-03-29 Abbott Cardiovascular Systems Inc. Drug coated balloon with in-situ formed drug containing microspheres
WO2012111852A1 (ja) * 2011-02-17 2012-08-23 帝人ファーマ株式会社 椎体骨折治療剤及びその評価方法
ES2882852T3 (es) 2011-03-16 2021-12-02 Kuros Biosurgery Ag Formulación farmacéutica para la utilización en la fusión espinal
KR101891673B1 (ko) 2011-06-07 2018-08-27 아사히 가세이 파마 가부시키가이샤 고순도 ｐｔｈ 함유 동결 건조 제제 및 그의 제조 방법
US9700485B2 (en) 2013-04-24 2017-07-11 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US11492386B2 (en) 2016-02-01 2022-11-08 Eli Lilly And Company Parathyroid hormone-anti-RANKL antibody fusion compounds
CN110520148A (zh) * 2017-02-01 2019-11-29 约翰霍普金斯大学 甲状旁腺激素与退行性椎间盘疾病的再生
JP6577683B2 (ja) * 2017-09-22 2019-09-18 旭化成ファーマ株式会社 安定性に優れるテリパラチド含有液状医薬組成物
CN111447943A (zh) 2018-10-29 2020-07-24 旭化成制药株式会社 以按每周2次的频率给予特立帕肽或其盐为特征的骨质疏松症的预防或治疗方法
WO2021030222A1 (en) 2019-08-09 2021-02-18 Flagship Pioneering Innovations Vi, Llc Modulators of parathyroid hormone receptor (pthr1)
GB2590692A (en) * 2019-12-24 2021-07-07 Corthotec Ltd Composition for improved bone fracture healing

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086196A (en) 1975-03-28 1978-04-25 Armour Pharmaceutical Company Parathyroid hormone
IL78342A (en) * 1985-04-04 1991-06-10 Gen Hospital Corp Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof
DE3935738A1 (de) 1989-10-27 1991-05-08 Forssmann Wolf Georg Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff
US5208041A (en) 1991-05-23 1993-05-04 Allelix Biopharmaceuticals Inc. Essentially pure human parathyroid hormone
CA2126299C (en) 1994-06-20 2000-12-12 Gordon E. Willick Parathyroid hormone analogues for the treatment of osteoporosis
JPH0873376A (ja) * 1994-09-07 1996-03-19 Asahi Chem Ind Co Ltd 骨粗鬆症治療薬
US5747456A (en) 1994-12-19 1998-05-05 Beth Israel Deaconess Medical Center Continuous low-dose administration of parathyroid hormone or its agonist
WO1996019246A1 (en) * 1994-12-19 1996-06-27 Beth Israel Hospital Association Continuous low-dose administration of parathyroid hormone or its agonist
CA2206657C (en) * 1994-12-22 2009-05-19 Astra Aktiebolag Therapeutic preparation for inhalation containing parathyroid hormone, pth
JPH08310965A (ja) 1995-05-16 1996-11-26 Chugai Pharmaceut Co Ltd 骨癒合促進剤
EP1005359B1 (en) 1997-09-09 2005-06-15 F. Hoffmann-La Roche Ag FRACTURE HEALING USING PTHrP ANALOGS
ZA9811127B (en) 1997-12-09 2000-07-11 Lilly Co Eli Stabilized teriparatide solutions.
DZ2873A1 (fr) * 1998-08-19 2003-12-15 Lilly Co Eli Procédé pour augmenter la dureté et la rigidité osseuse.
US20040033950A1 (en) 2000-09-26 2004-02-19 Hock Janet M. Method of increasing bone toughness and stiffness and reducing fractures
US6907597B1 (en) 2000-10-13 2005-06-14 Ati International Srl Method and apparatus for constructing an executable program in memory
US6967759B2 (en) 2001-12-31 2005-11-22 Texas Instruments Incorporated Pulse width modulation sequence generation
JP5796714B2 (ja) 2012-01-13 2015-10-21 株式会社リコー 定着装置及び画像形成装置
EP2949301B1 (en) 2014-05-27 2018-04-18 The Procter and Gamble Company Absorbent core with curved and straight absorbent material areas

Also Published As

Publication number Publication date
ES2621653T3 (es) 2017-07-04
PT2266598T (pt) 2017-05-02
PL343595A1 (en) 2001-08-27
CN1205997C (zh) 2005-06-15
DK2266598T3 (en) 2017-05-15
KR100454207B1 (ko) 2004-10-26
CO5130020A1 (es) 2002-02-27
JP2017190332A (ja) 2017-10-19
US7163684B2 (en) 2007-01-16
AU5575099A (en) 2000-03-14
ID29039A (id) 2001-07-26
PL201688B1 (pl) 2009-04-30
DK1769804T3 (da) 2012-10-15
EP2266598B1 (en) 2017-02-22
CN1308545A (zh) 2001-08-15
EP2907522B1 (en) 2017-08-02
KR20010072763A (ko) 2001-07-31
HK1212602A1 (zh) 2016-06-17
EA003362B1 (ru) 2003-04-24
HK1030545A1 (en) 2001-05-11
CZ301017B6 (cs) 2009-10-14
DE69904918D1 (de) 2003-02-20
US20050197294A1 (en) 2005-09-08
DK2907522T1 (da) 2015-10-19
JP6177718B2 (ja) 2017-08-09
EA200001015A1 (ru) 2001-02-26
ES2549551T3 (es) 2017-11-27
HU1200430D0 (hu) 2001-11-28
DE15152726T1 (de) 2015-12-10
NO20072983L (no) 2000-11-24
HU230697B1 (hu) 2017-09-28
HUP0101594A3 (en) 2002-01-28
DK1059933T3 (da) 2003-04-07
ES2190244T3 (es) 2003-07-16
CZ20004134A3 (cs) 2001-08-15
DZ2873A1 (fr) 2003-12-15
JP2011021035A (ja) 2011-02-03
PT1059933E (pt) 2003-06-30
JP2014139220A (ja) 2014-07-31
CA2325371A1 (en) 2000-03-02
EP2907522A1 (en) 2015-08-19
MY129227A (en) 2007-03-30
AR033639A1 (es) 2004-01-07
CY1119552T1 (el) 2018-03-07
ATE231000T1 (de) 2003-02-15
JP2015028065A (ja) 2015-02-12
BR9909445A (pt) 2000-12-12
AU746277B2 (en) 2002-04-18
NO20005947D0 (no) 2000-11-24
UA72205C2 (uk) 2005-02-15
IL138829A0 (en) 2001-10-31
HK1102496A1 (en) 2007-11-23
WO2000010596A1 (en) 2000-03-02
US6977077B1 (en) 2005-12-20
CY1113343T1 (el) 2016-06-22
ES2393200T3 (es) 2012-12-19
ES2549551T1 (es) 2015-10-29
PT2907522T (pt) 2017-10-23
DK2907522T3 (en) 2017-10-23
NZ507056A (en) 2003-10-31
DE69904918T2 (de) 2003-11-13
TW576747B (en) 2004-02-21
PT1769804E (pt) 2012-11-13
EP1059933A1 (en) 2000-12-20
NO323984B1 (no) 2007-07-30
TR200003455T2 (tr) 2001-06-21
IL138829A (en) 2011-01-31
HRP20000755A2 (en) 2001-02-28
CA2325371C (en) 2004-08-17
HUP0101594A2 (hu) 2001-11-28
EP1059933B1 (en) 2003-01-15
JP2002523375A (ja) 2002-07-30
EP2266598A1 (en) 2010-12-29
PE20001089A1 (es) 2000-11-04

Similar Documents

Publication Publication Date Title
NO20005947L (no) Fremgangsmåte for å öke benhardhet og stivhet og redusere frakturer
FR2775183B1 (fr) Prothese inter-epineuse
FR2787313B1 (fr) Implant d'osteosynthese
HUP0104633A3 (en) Improved device for the external fixation of bones fractures, in particular ankle fractures
DE69922075D1 (de) Orthopädische Knochenplatte
NO20013193L (no) Fremgangsmåte og kit for å ekstrahere prionprotein
DE60015879D1 (de) Wirbelsäulenimplantat
ATE284466T1 (de) Weiches seidenpapier
DE59701304D1 (de) Wirbelsäulenorthese
ZA995980B (en) Reduction forceps for long bone fractures.
NO943852D0 (no) Fremgangsmåte for å hemme bentap
FR2846545B1 (fr) Implant d'osteosynthese intramedullaire
GB9920785D0 (en) Bone splint
NO975581D0 (no) Fremgangsmåte for å redusere bentap
NO20011806D0 (no) Mykt tissuepapir
NO20022057D0 (no) Fremgangsmåte og sammensetning for å behandle lungesykdommer
NO20013085D0 (no) Fosfororganiske forbindelser og deres anvendelse
DE29600369U1 (de) Chirurgische Knochenmühle
DE29904696U1 (de) Distraktor für Knochenteile
NO975560D0 (no) Fremgangsmåte for å redusere bentap
ID24759A (id) Metoda untuk meningkatkan volume tulang
DE29903855U1 (de) Implantat zum Aneinanderbefestigen von Knochen
DE29820434U1 (de) System zum Fixieren von Knochenfrakturen
ZA200004993B (en) Method of increasing bone toughness and stiffness and reducing fractures.
NO940896D0 (no) Ortopedisk brudd-stabilisator

Legal Events

Date Code Title Description
MK1K Patent expired